# Gracili Therapeutics, Inc. — Form D

Gracili Therapeutics, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-17. $100K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-03-17
- Form: D
- Accession: 0001567619-20-006578
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $100K
- Investors: 1
- Date of first sale: 2020-03-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-363080

## Issuer

- Name: Gracili Therapeutics, Inc.
- CIK: 0001806319
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 15 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Phone: 919-549-8854

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Atul Chopra | Director | Research Triangle Park, NC |
| Andy Jordan | Director | Research Triangle Park, NC |
| John Taylor | Director | San Jose, CA |
| Atul Chopra | Executive Officer | Research Triangle Park, NC |
| John Taylor | Executive Officer | San Jose, CA |

## More

- [CIK 1806319 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1806319&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-20-006578.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.